Showing results (2361-2370 of 4,615) with videos related to
Sort By:
Pageof 462
Chemmedchem|November 22, 2017
Synthetic Oligosaccharide Libraries and Microarray Technology: A Powerful Combination for the Success of Current Glycosaminoglycan InteractomicsVitor H Pomin, Xu WangChemmedchem|October 29, 2017
Design, Synthesis, Molecular Modeling, and Biological Evaluation of Novel Amine-based Histone Deacetylase InhibitorsHazem Abdelkarim, Raghupathi Neelarapu, Antonett Madriaga, et al.Chemmedchem|September 30, 2017
Dynamic Combinatorial Chemistry to Identify Binders of ThiT, an S-Component of the Energy-Coupling Factor Transporter for ThiamineLeticia Monjas, Lotteke J Y M Swier, Inda Setyawati, et al.Chemmedchem|July 15, 2016
Discovery of HIV Type 1 Aspartic Protease Hit Compounds through Combined Computational ApproachesDimitrios Xanthopoulos, Eftichia Kritsi, Claudiu T Supuran, et al.Chemmedchem|April 1, 2018
Niclosamide, a Drug with Many (Re)purposesHachemi Kadri, Olivia A Lambourne, Youcef MehellouChemmedchem|December 15, 2018
A Triazolotriazine-Based Dual GSK-3β/CK-1δ Ligand as a Potential Neuroprotective Agent Presenting Two Different Mechanisms of Enzymatic InhibitionSara Redenti, Irene Marcovich, Teresa De Vita, et al.Chemmedchem|December 15, 2018
A Scaffold-Hopping Strategy toward the Identification of Inhibitors of Cyclin G Associated KinaseRandy Wouters, Junjun Tian, Piet Herdewijn, et al.Chemmedchem|October 28, 2006
Nanomolar inhibition of type II dehydroquinase based on the enolate reaction mechanismMiguel D Toscano, Richard J Payne, Akira Chiba, et al.Chemmedchem|November 8, 2006
Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies (part 2)Antonio Lavecchia, Roberta Costi, Marino Artico, et al.Chemmedchem|September 7, 2006
Towards the development of mixed MT(1)-agonist/MT(2)-antagonist melatonin receptor ligandsGilberto Spadoni, Annalida Bedini, Tomaso Guidi, et al.Pageof 462